InvestorsHub Logo
Followers 10
Posts 1064
Boards Moderated 0
Alias Born 11/24/2007

Re: DewDiligence post# 13374

Saturday, 04/18/2015 3:15:55 PM

Saturday, April 18, 2015 3:15:55 PM

Post# of 20689
Yes Craig Wheeler specifically said he was very pleased on how the letter to CP was written. He was suggesting It gave the criteria but not spoon feeding on the exact method. I am also pleased that now with a generic approved, Copaxone ANDA is now not a priority review.